CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: Failure of empirical chemotherapy

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 6, 2008, Pages 1472-1474

  Boyer Mariotte, Sophie ^a,b   Duboc, Pauline ^a   Bonacorsi, Stéphane ^c   Lemeland, Jean François ^a   Bingen, Edouard ^c   Pinquier, Didier ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Enterobacteriaceae; ESBLs; Resistance to cephalosporins; Very low birth weight

Indexed keywords

AMINOGLYCOSIDE; BACTERIAL ENZYME; C REACTIVE PROTEIN; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; ENZYME CTX M 15; IMIPENEM; METRONIDAZOLE; NETILMICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ABDOMINAL DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APNEA; BACTERIAL GROWTH; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; ESCHERICHIA COLI; FATALITY; HUMAN; HYPERGLYCEMIA; INFANT; INFLAMMATION; LETTER; LEUKOPENIA; NASOPHARYNGEAL ASPIRATION; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; PHENOTYPE; PROTEIN CEREBROSPINAL FLUID LEVEL; SEPTIC SHOCK; VERY LOW BIRTH WEIGHT;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DNA FINGERPRINTING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; HUMANS; INFANT, NEWBORN; MENINGITIS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RIBOTYPING;

EID: 56649120701     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn362     Document Type: Letter

References (8)

1. Stoll BJ, Hansen N, Fanaroff AA et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347: 240-7.
2. Bizzarro MJ, Dembry LM, Baltimore RS et al. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121 689-96.
3. Livermore DM, Canton R, Gniadkowski M et al. CTX-M: Changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165-74.
4. Bonacorsi S, Clermont O, Houdouin V et al. Molecular analysis and experimental virulence of French and North American Escherichia coli neonatal meningitis isolates: Identification of a new virulent clone. J Infect Dis 2003; 187: 1895-906.
5. Eckert C, Gautier V, Saladin-Allard M et al. Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004; 48: 1249-55.
6. Ramdani-Bouguessa N, Mendonc,a N, Leitao J et al. CTX-M-3 and CTX-M-15 extended-spectrum β-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J Clin Microbiol 2006; 44: 4584-6.
7. Pitout JD, Nordmann P, Laupland KB et al. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-9.
8. Leibovitz E. The use of fluoroquinolones in children. Curr Opin Microbiol 2006; 18: 64-70.